Mark G. Midei, MD @markgmidei

From now on, ending a sentence with a preposition is something up with which I will not put. Joined March 2011

Tweets

288
Followers

151
Following

493
Likes

70

Mark G. Midei, MD @markgmidei

3 years ago

Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Initiation of Phase II Study of naronapride in patients with gastroparesis prn.to/3YubRIJ

1 1 2 350 0

Labiotech.eu @Labiotech_eu

3 years ago

Renexxion has opened an IND application with the FDA for naronapride to treat GI motility disorders in patients with cystic fibrosis. 👇🏻 #biotech #lifesciences #news labiotech.eu/trends-news/re…

0 1 2 510 0

Mark G. Midei, MD @markgmidei

3 years ago

Renexxion Ireland opens IND for naronapride to treat GI Motility Disorders in patients with Cystic Fibrosis prn.to/3CBZqBO

0 0 3 227 0

C. Michael Gibson MD @CMichaelGibson

3 years ago

The Heartline Study is a randomized trial of the Apple watch vs no watch to detect atrial fibrillation & use of apps to improve heart health. I am pleased to announce that we have completed enrollment in the study with more than 34,000 participants ! heartline.com

6 23 109 30K 5

CurePSP @CurePSP

3 years ago

@markgmidei joins us with a 28-year clinical career in interventional cardiology and electrophysiology research. Thank you for your discussion on Drug Trials: Mitochondria-Directed Agents. #Neuro22

0 1 1 0 0

Download Image

Mark G. Midei, MD @markgmidei

3 years ago

BioJiva release Phase 2 ALS study results: bit.ly/3eTKwh2

0 0 2 0 0

Elon Musk @elonmusk

5 years ago

If there’s ever a scandal about me, *please* call it Elongate

19K 50K 679K 0 2K

Mark G. Midei, MD @markgmidei

4 years ago

More positive press for Renexxion Ireland.

Charlie Taylor @ChasTaylor

4 years ago

More positive press for Renexxion Ireland.

11 10 101 0 0

0 0 1 0 0

Mark G. Midei, MD @markgmidei

4 years ago

Renexxion Ireland enters a share subscription agreement for up to $100 Million: prn.to/3rlPHtx

0 0 1 0 0

Mark G. Midei, MD @markgmidei

4 years ago

New patent issued for GI prokinetic agent naronapride: yhoo.it/342KJsR

0 0 0 0 0

Mark G. Midei, MD @markgmidei

4 years ago

RT001 in animal models of retinal degeneration: bit.ly/3DVAALj

0 0 0 0 0

Mark G. Midei, MD @markgmidei

4 years ago

RT001--Survival benefit in Patients with INAD: bit.ly/3mx2cPE

0 1 2 0 0

Mark G. Midei, MD @markgmidei

4 years ago

Enrollment of 42 patients in PSP clinical trial is now complete. Clinical trial results in 12 months: bit.ly/3sgm1xq

0 0 1 0 0

PSP & CBD Awareness @PSP_CBD_MSA

4 years ago

This is a randomized, placebo-controlled trial of RT001 in patients with PSP. RECRUITING Agaharied Teaching Hospital, University of Munich Munich, MD, Germany, 21111 Contact: Mark G. Midei, MD [email protected] @PSPGesellschaft @PSP_Bayern clinicaltrials.gov/ct2/show/NCT04…